UNSPSC 51142550: Ciladopa hydrochloride

This classification denotes a dopamine agonist with the molecular formula C21H26N2O4.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ASR1NR721I. The term ciladopa hydrochloride is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule ciladopa hydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, CILADOPA HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: COC1CCC(CC1OC)[C@@H](CN2CCN(CC2)C3CCCCCC3=O)O.CL.

UNSPSC 51142550 Ciladopa hydrochloride is a Commodity code that shows little relevant recent activity aligned with its narrow pharmaceutical scope. The three most recent state and local opportunities tagged under this code—Seminole County's procurement of naloxone and drug deactivation systems, Texas HHS's request for information on direct-to-manufacturer prescription programs, and Minnesota's MMCAP cooperative purchasing agreement for generic multi-source pharmaceuticals and OTC products—do not feature ciladopa hydrochloride as a line item or focus. The mismatch between the code's specificity (a single active pharmaceutical ingredient) and the breadth of the solicitations suggests either tagging inconsistency or that ciladopa hydrochloride procurement does not appear in publicly available state and local bid opportunities at present.

The issuing bodies in the recent record span state health agencies (Texas HHS Commission, Minnesota Department of Administration), county health departments (Seminole County, Florida), and cooperative purchasing alliances (MMCAP, covering multiple states including Oregon). The geographic spread covers Texas, Minnesota, Florida, and participating MMCAP jurisdictions, but none of these opportunities names ciladopa hydrochloride as a deliverable. Unless your firm supplies ciladopa hydrochloride as part of a broader generic pharmaceutical or OTC product roster aligned with cooperative purchasing vehicles such as MMCAP or direct-to-state contracts, this code does not currently represent a pursuit opportunity. Monitor MMCAP and state health department RFPs for generic pharmaceutical schedules that may include the ingredient, but do not expect dedicated solicitations under this Commodity code.